Metabolic Disorders Clinical Trials
2 recruiting trials for Metabolic Disorders. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Metabolic Disorders clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1), Qifu Li (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is observe (other, 1 trial).
Track Metabolic Disorders trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
A Natural History Study of Metabolic Sizing in Health and Disease
Background: Scientists have long used simple measures (such as height and weight) to estimate how much a person s body uses food (calories) as energy, as commonly called the...
Environment, Inflammation and Metabolic Diseases Study
The aim is to establish an effective and practical early warning model for endocrine and metabolic diseases based on an environmental-gene-protein panoramic network, to uncover...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Metabolic Disorders, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Metabolic Disorders, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Metabolic Disorders, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.